Cetrorelix Acetate Kit
Product Images NDC 71288-558

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 71288-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cet02 0000 01 V2)

Chemical structure of Cetrorelix Acetate showing its peptide chain with labeled amino acid residues and acetyl group (AcOH).*

FDA Label Image

Figure 1 (Cet02 0000 02)

An instructional illustration showing a hand performing a subcutaneous injection, likely demonstrating the administration of Cetrorelix Acetate kit. The image depicts one hand holding the injection site while the other hand holds the syringe at an angle ready for injection.*

FDA Label Image

Figure 2 (Cet02 0000 03)

Cetrorelix Acetate kit includes a vial, two syringes, two needles, and an alcohol prep pad arranged on a white surface. The kit is intended for subcutaneous administration and is labeled with Meitheal Pharmaceuticals Inc. as the labeler.*

FDA Label Image

Figure 3 (Cet02 0000 04)

An instructional illustration showing two steps for vial use: first, removing the protective cap by pulling it upward; second, wiping or preparing the vial's rubber stopper with a swab held by hand. This kit-related image likely relates to proper vial preparation for subcutaneous administration.*

FDA Label Image

Figure 4 (Cet02 0000 05)

An instructional illustration showing a syringe with a needle cap that is being removed by twisting or pulling. It demonstrates preparation steps likely related to subcutaneous injection use.*

FDA Label Image

Figure 5 (Cet02 0000 06)

An instructional line drawing illustrating the use of a syringe to withdraw liquid from a vial, likely representing preparation of a subcutaneous injection in a medication kit.*

FDA Label Image

Figure 6 (Cet02 0000 07)

An instructional illustration showing a hand using a syringe to withdraw liquid from a vial. The image likely demonstrates the preparation or administration process related to a subcutaneous injection.*

FDA Label Image

Figure 7 (Cet02 0000 08)

An instructional illustration showing the process of assembling or preparing a subcutaneous injection kit. The image depicts a vial above, a syringe below, and an object that appears to be a needle or connector in between, indicating the steps to connect the components for drug administration.*

FDA Label Image

Figure 8 (Cet02 0000 09)

An instructional illustration showing a syringe with arrows indicating a twisting or turning motion, likely demonstrating how to mix or prepare a medication before use. The syringe is depicted clearly with an emphasis on the rotation action.*

FDA Label Image

Figure 9 (Cet02 0000 10)

An instructional illustration showing a syringe with an arrow pointing downward along its barrel, indicating the syringe plunger being pushed down. This likely relates to the subcutaneous administration of the medication.*

FDA Label Image

Figure 10 (Cet02 0000 11)

An instructional illustration showing two steps likely related to the subcutaneous administration of Cetrorelix Acetate kit. The first frame depicts a person lifting their shirt to expose the lower abdomen area. The second frame shows a close-up of a hand administering an injection into the skin of a forearm or abdominal area.*

FDA Label Image

Figure 11 (Cet02 0000 12)

An instructional illustration showing a hand placing a syringe into a rectangular container labeled 'SHARPS CONTAINER' for safe disposal. The container appears to be designed for the subcutaneous administration kit associated with Cetrorelix Acetate.*

FDA Label Image

Principal Display Panel – Cetrorelix Acetate For Injection 0.25 mg Vial Label (Cet02 0000 13 V3)

Label for Cetrorelix Acetate for Injection 0.25 mg per vial, a subcutaneous injection kit. The label states it is for subcutaneous use only, with storage instructions to refrigerate between 2° to 8°C (36° to 46°F). It is a sterile single-dose vial with discard instructions for unused portions. Manufactured for Meitheal Pharmaceuticals Inc., Chicago, IL, made in China.*

FDA Label Image

Principal Display Panel – Cetrorelix Acetate For Injection 1 mL Diluent Syringe Label (Cet02 0000 14 V3)

Packaging label for Sterile Water for Injection, USP, 1 mL single-dose prefilled syringe. Label includes NDC 71288-557-81, indicates it is Rx-only, manufactured for Meitheal Pharmaceuticals, and made in China. The label also notes discard of unused portion and pH range of 5 to 8.*

FDA Label Image

Principal Display Panel – Cetrorelix Acetate For Injection Kit Tray Label (Cet02 0000 15 V3)

Label for Cetrorelix Acetate for Injection 0.25 mg per vial, a single-dose kit for subcutaneous use. Contains one single-dose vial with lyophilized powder, one single-dose prefilled syringe with diluent, one 20-gauge needle, and one 27-gauge needle. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL. Storage instructions indicate refrigeration at 2° to 8°C (36° to 46°F).*

FDA Label Image

Principal Display Panel – Cetrorelix Acetate For Injection Kit Carton (Cet02 0000 16 V4)

Packaging label for Cetrorelix Acetate for Injection 0.25 mg per vial, a single-dose kit for subcutaneous use. The label states it is sterile and must be stored refrigerated between 2° to 8°C (36° to 46°F). One carton includes a single-dose vial with lyophilized powder, a prefilled syringe with diluent, and 20- and 27-gauge needles. Labeler is Meitheal Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.